Plexus Corp. (NASDAQ:PLXS – Get Free Report) Director Karen Marie Rapp sold 500 shares of the company’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $240.87, for a total transaction of $120,435.00. Following the sale, the director directly owned 7,535 shares in the company, valued at $1,814,955.45. This trade represents a 6.22% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Plexus Stock Down 0.6%
Shares of NASDAQ:PLXS opened at $239.47 on Tuesday. The company has a market capitalization of $6.41 billion, a price-to-earnings ratio of 35.32 and a beta of 0.90. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72. The business’s 50-day moving average is $262.34 and its 200-day moving average is $244.46. Plexus Corp. has a 1 year low of $132.03 and a 1 year high of $307.06.
Plexus (NASDAQ:PLXS – Get Free Report) last issued its earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping analysts’ consensus estimates of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The business had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.23 billion. During the same period in the previous year, the company posted $1.64 earnings per share. The firm’s revenue for the quarter was up 28.2% on a year-over-year basis. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Equities research analysts predict that Plexus Corp. will post 7.11 earnings per share for the current year.
Institutional Investors Weigh In On Plexus
Wall Street Analyst Weigh In
PLXS has been the subject of several analyst reports. Needham & Company LLC reiterated a “buy” rating and issued a $310.00 target price on shares of Plexus in a report on Friday, August 14th. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target on the stock in a report on Friday, July 31st. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Stifel Nicolaus increased their price objective on shares of Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Finally, Weiss Ratings cut shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. According to data from MarketBeat.com, Plexus currently has an average rating of “Buy” and a consensus target price of $273.00.
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Plexus
- Boarding Call: EHang Secures First-Mover Altitude
- 3 Space Stocks: Ready for Liftoff or Burning Up on Reentry?
- Space Race Meets Ground Reality for Tower REITs
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
